These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 15259057)
1. Hepatitis E: an overview and recent advances in vaccine research. Wang L; Zhuang H World J Gastroenterol; 2004 Aug; 10(15):2157-62. PubMed ID: 15259057 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis E: a neglected threat. Myint KS; Gibbons RV Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):211-2. PubMed ID: 17658568 [TBL] [Abstract][Full Text] [Related]
3. Toward the development of a hepatitis E vaccine. Kamili S Virus Res; 2011 Oct; 161(1):93-100. PubMed ID: 21620908 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis E vaccines: progress and prospects. Worm HC; Wirnsberger G Drugs; 2004; 64(14):1517-31. PubMed ID: 15233590 [TBL] [Abstract][Full Text] [Related]
5. Advances in hepatitis E - II: Epidemiology, clinical manifestations, treatment and prevention. Goel A; Aggarwal R Expert Rev Gastroenterol Hepatol; 2016 Sep; 10(9):1065-74. PubMed ID: 27148907 [TBL] [Abstract][Full Text] [Related]
6. Making the case for the development of a vaccination against hepatitis E virus. Haffar S; Bazerbachi F; Lake JR Liver Int; 2015 Feb; 35(2):311-6. PubMed ID: 24836400 [TBL] [Abstract][Full Text] [Related]
7. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus. Mazalovska M; Kouokam JC Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441 [TBL] [Abstract][Full Text] [Related]
8. Development of new hepatitis E vaccines. Cao Y; Bing Z; Guan S; Zhang Z; Wang X Hum Vaccin Immunother; 2018; 14(9):2254-2262. PubMed ID: 29708836 [TBL] [Abstract][Full Text] [Related]
9. Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles. Li TC; Suzaki Y; Ami Y; Dhole TN; Miyamura T; Takeda N Vaccine; 2004 Jan; 22(3-4):370-7. PubMed ID: 14670318 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis E: an overview and recent advances in clinical and laboratory research. Aggarwal R; Krawczynski K J Gastroenterol Hepatol; 2000 Jan; 15(1):9-20. PubMed ID: 10719741 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis E virus: the current scenario. Kumar S; Subhadra S; Singh B; Panda BK Int J Infect Dis; 2013 Apr; 17(4):e228-33. PubMed ID: 23313154 [TBL] [Abstract][Full Text] [Related]
16. A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice. Xiang K; Kusov Y; Ying G; Yan W; Shan Y; Jinyuan W; Na Y; Yan Z; Hongjun L; Maosheng S Viruses; 2017 Sep; 9(9):. PubMed ID: 28914805 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis E virus. Panda SK; Thakral D; Rehman S Rev Med Virol; 2007; 17(3):151-80. PubMed ID: 17051624 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology of hepatitis E: current status. Aggarwal R; Naik S J Gastroenterol Hepatol; 2009 Sep; 24(9):1484-93. PubMed ID: 19686410 [TBL] [Abstract][Full Text] [Related]
20. Development of a vectored vaccine against hepatitis E virus. Trabelsi K; Kamen A; Kallel H Vaccine; 2014 May; 32(24):2808-11. PubMed ID: 24583005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]